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Abstract This review summarizes the types of evidence that
can be invoked in order to demonstrate that a virally encoded
protein possesses ion channel activity that is intrinsic to the life
cycle of the virus. Ion channel activity has been proposed to be a
key step in the life cycle of in£uenza virus, and the protein
responsible for this activity has been proposed to be the M2
protein encoded by the virus. This review contrasts the evidence
supporting the conclusion that the A/M2 protein of in£uenza A
virus has intrinsic ion channel activity with the evidence that the
3AB protein encoded by the human rhinovirus possesses intrinsic
ion channel activity.
# 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
If a cellularly encoded protein is suspected to function as an
ion channel in a particular type of cell, it is possible to record
directly from that cell, perturb the recording conditions, alter
the gene expression in that cell type, and make relatively
straightforward deductions about the possibility that the pro-
tein in question functions as an ion channel or a subunit of an
ion channel complex. The situation is more complicated, how-
ever, for ion channel proteins that are encoded by viruses
because they often encode proteins for which there is no
known homologue and because the virally encoded protein
might function either in the virus particle (virion) itself or in
the infected cell, and, causing further complications for anal-
ysis, it might upregulate an endogenous cellular ion channel
that is normally silent.
Electrical activity has been reported for several proteins
encoded by viruses: NB of in£uenza B virus [1], VPU of
human immunode¢ciency virus [2], A/M2 protein of in£uenza
A virus [3], BM2 protein of in£uenza B virus [4], and Kþ
channel protein of Chlorella virus [5], and for some of these
proteins the claim has been made that these proteins serve to
provide ion channel activity that is needed at some stage dur-
ing the life cycle of the virus. The aim of this review is to
evaluate the type of evidence that can be used to demonstrate
intrinsic ion channel activity of a protein, particularly for
proteins that are encoded by viruses. In this review we will
distinguish an ion channel from a pore by the criteria that ion
channels are both selective for a limited range of ions and
possess the property of being closed until they are activated
by a chemical or electrical stimulus.
The principal experimental obstacle to demonstrating ion
channel activity of virally encoded proteins is the di⁄culty
in recording ion channel activity from the extremely small
viruses or intracellular organelles that contain the presumed
ion channel proteins. Even if it were possible to record from
these structures or infected cells it would still be necessary to
distinguish the ion channel activity of the virally encoded
protein from that of host cell proteins. Instead of recording
from a virus, organelle or host cell, the properties of presumed
ion channel proteins have been studied in expression systems
and these properties compared with those expected from the
life cycle of the virus at the relevant stage proposed for the
protein. The greater the number of correlations that can be
made between the ion channel function predicted from the
biological role and the actual ion channel function in an ex-
pression system, the stronger is the case that can be made for
intrinsic ion channel activity. This review will give two exam-
ples of virally encoded proteins, the A/M2 protein of in£uenza
virus and the 3AB protein of rhinovirus, contrasting the evi-
dence that each serves as an ion channel in the life cycle of the
virus.
2. The A/M2 protein of in£uenza virus
The case for intrinsic ion channel activity that plays an
essential role in the viral life cycle is perhaps strongest for
the A/M2 protein of in£uenza A virus because this channel
has been studied for some time and, it turns out, the antiviral
compound amantadine acts by inhibiting the ion channel ac-
tivity. The in£uenza A virion is bounded by a membrane
formed by budding from the plasma membrane of the infected
cell and contains three integral membrane proteins, hemagglu-
tinin (HA), neuraminidase and A/M2 (reviewed in [6]). The
evidence that the A/M2 protein has intrinsic ion channel ac-
tivity does not come only from measurements of its ion chan-
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Fig. 1. Comparison of the life cycles of the in£uenza virus (A) and rhinovirus (B). In A the steps for which the M2 protein is thought to have
a role are shown and in B the location of the 3AB protein in the replication complex is shown.
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nel activity in expression systems, but also from measurements
on mutant A/M2 proteins, a detailed knowledge of the life
cycle of the virus, and experiments employing the antiviral
drug amantadine (see Fig. 1A).
In£uenza A virus HA binds to a sialic acid receptor on the
surface membrane of the infected cell and is then endocytosed
(reviewed in [6]). While in the acidic endosome, the HA pro-
tein undergoes a conformational change to its low pH form
that exposes a hydrophobic fusion peptide, and after fusion
the interior of the virus is exposed to the cytoplasm of the
infected cell. However, fusion alone is not su⁄cient for the
release of the viral genetic material (uncoating) because the
ribonuclear proteins (RNPs) are only released from the matrix
(M) protein at low pH [7]. For this reason, a low pH step is
needed for uncoating. Several lines of evidence implicated the
A/M2 protein to be responsible for this acidi¢cation and led
to the postulate that the A/M2 protein might have ion channel
activity [8,9]. This ion channel activity was postulated to cause
acidi¢cation of the virion while it is contained within the
acidic endosome and presumably to continue to provide acid-
i¢cation after the process of fusion has begun in order to
maintain the low pH conditions needed to complete release
of the RNPs from the M protein (see Fig. 1A, steps 3 and 4).
The ¢rst line of evidence implicating the A/M2 protein in
the acidi¢cation of the virion came from experiments with
amantadine, which inhibits the ‘early’ uncoating step in rep-
lication; this evidence has been reviewed [10,11]. Amantadine-
resistant ‘escape’ mutant viruses contain alterations in amino
acids in the A/M2 protein transmembrane (TM) domain [12],
suggesting that the inhibiting molecule and the A/M2 protein
interact in some way. The notion that the A/M2 protein has
ion channel activity or is able to accomplish acidi¢cation
came from experiments in which a ‘late’ phase of the infective
cycle, in which the HA protein is transported from the endo-
plasmic reticulum to the surface of the infected cells, was
studied (Fig. 1A, step 6). It had been known that the HA
protein of certain strains of in£uenza is inserted into the cell
membrane in its low pH conformational form when the in-
fected cells were exposed to micromolar concentrations of
amantadine [8], presumably due to the low pH of the trans-
Golgi network [13^15]. When the ionophore monensin, which
catalyzes the exchange of Naþ for Hþ across membranes, was
added to the amantadine-treated infected cells, the HA was
inserted into the plasma membrane in its high pH form, sug-
gesting that the A/M2 protein and monensin [8,15] both act to
shunt the pH gradient across the Golgi membrane.
The A/M2 ion channel protein is a homotetrameric integral
membrane protein with each chain of the mature protein con-
taining 96 amino acid residues [9,16^22]. The coding regions
for the A/M2 protein have been conserved in all known
strains of avian, swine, equine and human in£uenza A viruses
and the amino acid sequence of the A/M2 protein TM domain
has been conserved to a greater extent than the remainder of
the protein [23]. The TM domain consists of 19 residues and
contains both polar residues and a histidine residue, making it
possible for the A/M2 protein TM domain to constitute the
proteinaceous core (the channel pore) that allows a £ux of
protons across the membrane.
Direct evidence that the A/M2 protein has ion channel ac-
tivity was obtained in recordings from oocytes of Xenopus
laevis [3] and mammalian cells [24^26] that expressed the pro-
tein. The oocytes were found to have ion channel activity that
was increased when the pH of the solution bathing the
N-terminal ectodomain of the protein was lowered [24,27^
29]. This activity is so strong that the oocytes and mammalian
cells can become acidi¢ed in a short time [26,30] when bathed
in a mildly acidic solution. The ion channel activity and acid-
i¢cation were both inhibited by amantadine at micromolar
concentrations [31]. However, these ¢ndings, although consis-
tent with intrinsic ion channel activity, were not su⁄cient to
demonstrate that the activity was intrinsic to the A/M2 pro-
tein and not merely the result of upregulation of a normally
silent, endogenous protein of the expressing cell. Two addi-
tional lines of evidence support this conclusion. First, muta-
tions made in the TM domain of the A/M2 protein produce
alterations in the functional characteristics of the protein that
are predicted from the biology of the virus infection or antici-
pated properties of the TM domain. A/M2 proteins with mu-
tations corresponding to those found in amantadine-resistant
escape mutant viruses have ion channel activity expressed in
oocytes that is resistant to amantadine [27,32]. Second, muta-
tions of two amino acids in the TM domain of the protein
produce distinct changes in the proton-handling properties of
the recorded activity. Proteins in which His37 has been mu-
tated to Gly, Ala or Glu possess ion channel activity di¡erent
from that of the wild-type (wt) protein in that their activity is
not speci¢c for protons and is relatively independent of the
pH of the solution bathing the N-terminal ectodomain than
the wt protein [28]. A/M2 mutant proteins for which Trp41 is
mutated to Ala, Cys, Phe or Tyr become activated at higher
values of pH than the wt protein and are capable of support-
ing e¥ux of protons into external media of high pH, in con-
trast to the wt protein which ‘captures’ protons in the cyto-
plasm [33]. In addition, puri¢ed recombinant A/M2 protein,
when introduced into arti¢cial lipid bilayers or vesicles, pro-
duces ion channel activity that is amantadine-sensitive [34,35]
and selective to protons [35]. These results, taken together,
show that the A/M2 protein has the necessary ion channel
activity in expression systems to explain its postulated role
in viral uncoating.
It is important to note that no one piece of evidence would
be su⁄cient to draw the conclusion that A/M2 protein has
intrinsic ion channel activity. For example, the activity re-
corded from arti¢cial lipid bilayers might not re£ect the ac-
tivity found in the virus or the infected cell. The activity
recorded in oocytes from wt A/M2 protein might be the result
of upregulation of an endogenous ion channel, as is the case
for other virally encoded proteins [36]. However, the body of
evidence from recordings of ion channel activity and knowl-
edge of the viral life cycle and the proposed role of the pro-
tein, together with the results of experiments with the inhib-
itor amantadine and amantadine-resistant escape mutations,
help to make a strong case for the conclusion of intrinsic ion
channel activity. Recently, this case for the A/M2 protein has
been strengthened by the ¢nding that the B/M2 protein of
in£uenza B virus is an integral membrane protein [4] that
has ion channel activity [37].
It should be noted that alterations in the morphological and
functional properties of cells ensue with time when they ex-
press large quantities of the A/M2 protein. Cells overexpress-
ing the A/M2 protein display a dilation of the lumen of the
Golgi apparatus and delay in transport through the secretory
pathway that are ameliorated by amantadine and mimicked
by treatment with the ionophore monensin [38]. In addition,
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we have noticed that cells overexpressing the A/M2 protein
also show a greater amount of non-speci¢c ‘leakage’ current
(that is not amantadine-sensitive) when studied with the patch
clamp method (mammalian cells) or with two-electrode vol-
tage clamp (oocytes) than do control cells that do not express
the protein. The amplitude of these leakage currents often
exceeded that of the amantadine-sensitive current after ex-
pressing the A/M2 protein for a few days. Thus, secondary
e¡ects due to the presence of the A/M2 protein have been
found, and these e¡ects are a consequence of the intrinsic
activity of the A/M2 protein. These secondary e¡ects give
rise to a general increase in ‘leakiness’ of the expressing cells,
and it would be incorrect to conclude that this increase in
‘leakiness’ in cells expressing the A/M2 protein represents an
intrinsic property of the protein.
3. The 3AB protein of human rhinovirus
In contrast to the membrane-bound in£uenza virus, the
human rhinovirus (HRV), a picornavirus, is bounded by an
eicosahedral protein capsid. Rather than budding from the
plasma membrane, as does the in£uenza virus, rhinovirus as-
sembly occurs via membrane-associated replication complexes
within the infected cell (see Fig. 1B). Replication of human
rhinovirus requires the 3AB protein complex which originates
from the long polypeptide chain encoded by the viral mRNA.
The polypeptide is cleaved by three virally encoded proteases
(including 2A and 3C) to produce 11 protein products from
three polypeptide regions. The third region, P3, encodes four
non-structural proteins (not found in the virion): 3A, 3B, 3C
and 3Dpol. A cis-acting replication element acts as the primary
template for uridylylation by 3Dpol of VPg (3B), which is
covalently linked to all newly synthesized viral positive and
negative strand RNAs and to nascent strands of the replica-
tion intermediate RNA [39]. VPg (3B) is donated to the rep-
lication complex by the precursor protein, 3AB [40], which
also interacts with 3Dpol and most likely tethers 3Dpol to
the replication membrane complex [41]. The 3A region of
the 3AB protein contains a conserved hydrophobic region of
22 amino acids [42] and is believed to be involved in seques-
tering the viral proteins needed for formation and function of
the replication complex [43]. Escape mutants from an antiviral
benzimidazole drug, enviroxime, map to the 3A region of the
3AB protein [43]. Since this portion of 3AB associates with
the membrane and expression of 3AB protein has been shown
to modify the permeability of the plasma membrane of cells
that express the protein [44,45], we considered the possibility
that 3AB protein might possess ion channel activity and that
enviroxime might function like amantadine, perhaps inhibit-
ing the ion channel activity.
3.1. 3AB protein and possible ion channel activity
Expression of 3AB protein in Escherichia coli causes the
bacterial cell to become more permeable to several small mol-
ecules [44], and cells infected with the poliovirus have been
shown to be more permeable to monovalent cations and small
molecules than uninfected cells [46^48]. We attempted to test
for possible ion channel activity of the 3AB protein by ex-
pressing the protein in oocytes of X. laevis, but we found that
after injection of mRNA encoding the 3AB protein an upreg-
ulation of an endogenous, cellular protein occurred; this type
of upregulation has been found for other virally encoded pro-
teins as well [49]. For this reason, we used a di¡erent ap-
proach to test for ion channel activity associated with the
3AB protein. This approach is to purify the protein, incorpo-
rate it into planar lipid bilayers, and test these bilayers for ion
channel activity.
Vesicles containing 3AB protein were incorporated into lip-
id bilayers using the nystatin^ergosterol technique, which al-
lows the quanti¢cation of the number of vesicles that were
incorporated into the bilayer prior to the appearance of ion
channel activity (see [50]). Brie£y, puri¢ed 3AB protein, 1 Wg/
Wl, was incorporated into arti¢cial vesicles using the freeze/
thaw/sonicate technique. Vesicles were composed of phospha-
tidylethanolamine:phosphatidylcholine:phosphatidylserine:er-
gosterol in the weight ratio 2.1:0.9:1:1 with 0.05 Wg/Wl of
Fig. 2. Example of variable activity of the 3AB protein from HRV-14 introduced into a planar lipid bilayer using the nystatin^ergosterol tech-
nique. Traces are o¡set by 20 pA each. The channel-like activity remains primarily closed at negative voltages and at positive voltages less
than +60 mV. Bath solutions for asymmetric 3AB analysis were 428 or 645 mM NaCl, 8 mM HEPES cis and 150 mM NaCl, 8 mM HEPES
trans.
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nystatin. These vesicles were fused with a 200^400 Wm diam-
eter planar lipid bilayer.
Electrical activity was observed in the form of multiple con-
ductance states for which the current was carried fairly non-
selectively by cations. An example of three main conductance
states; a medium amplitude (80 pSR 1 pS S.E.M.; n=6) con-
ductance, a slow gating subconductance (29 pSR 5 pS S.E.M.;
n=6) state and a full conductance (103 pSR 8 pS S.E.M.;
n=6) state characterized by rapid gating were observed [51].
In addition to these three conductance states, a sporadically
occurring state of large conductance (as large as 1 nS) and
medium conductance states which were highly voltage-depen-
dent when studied in asymmetric monovalent salt solutions
were also observed (Fig. 2) [51]. This electrical activity was
greatly reduced by boiling the protein prior to incorporation
into lipid vesicles. However, none of the electrical activity was
signi¢cantly inhibited by the antiviral enviroxime.
In order to determine if the electrical activity observed in
bilayers was enough to cause the membrane to become per-
meable to large molecules, 3AB protein was incorporated into
vesicles containing £uorescently labeled dextrans (FITC-dex-
tran) of various sizes. The e¥ux of the dextrans from these
vesicles was quanti¢ed. We found that FITC-dextran of mo-
lecular weight as high as 70 000 Da was able to escape from
3AB-containing vesicles but not from control vesicles (Fig. 3).
The results of this experiment are consistent with the large
(1 nS) conducting states seen for the ion channel activity as-
sociated with the 3AB protein. However, the e¥ux was also
not signi¢cantly inhibited by enviroxime.
Ion channel activity of crude replication complexes. Because
the 3AB protein is found in the replication complex in virus-
infected cells [52], we tested HRV-14 replication complexes for
ion channel activity. To do this, we incorporated crude repli-
cation complexes into planar lipid bilayers. We found that the
replication complex also demonstrated ion channel activity
when incorporated into planar lipid bilayers (Fig. 4). The
ion channel activity of the replication complex was similar
to that of 3AB protein in two respects. First, both channels
were fairly non-selective to various ions with a preference of
NasK. Second, both demonstrated mild pH sensitivity, with
both showing a decrease in conductance as pH was decreased.
The channels also di¡ered in several ways. The ion channel
activity associated with the replication complex had a longer
open time with a larger primary conductance state of 313 pS
( R 10 pS S.E.M.; n=3) than that associated with the 3AB
protein [51]. The ion channel activity associated with the
3AB protein also had more conductance states than did that
of the replication complex.
3.2. 3AB channel or 3AB pore?
The above results demonstrated that the 3AB protein is
capable of electrical activity in bilayers and permits leakage
of dextrans from vesicles. The question remained whether the
protein acted as an ion channel or as a pore. To help decide
this question we determined the quantity of 3AB protein that
was associated with a bilayer that had electrical activity. This
was done by counting the number of vesicles that were incor-
porated in the membrane before 3AB electrical activity was
observed and then multiplying the number of vesicles by the
average 3AB protein content per vesicle to obtain the number
of 3AB molecules that were incorporated in the bilayer.
Vesicle incorporation was determined by counting the num-
Fig. 3. Release of entrapped FITC-dextran from arti¢cial vesicles into which 3AB protein (His-tagged, S-sulfonate form) had been incorporated
in various concentrations. Vesicles containing £uorescein dextrans were prepared with a weight ratio of 9.1:1 of phosphatidylcholine to phos-
phatidylglycerol. The dried lipid ¢lm on the bottom of a round bottom £ask was resuspended in phosphate-bu¡ered saline (PBS) containing
10^20 mg/ml of FITC-dextran by vortexing, followed by sonication and freeze-thawing to produce large unilamellar vesicles. The vesicles were
sized through a 0.1 Wm ¢lter and then washed four times with PBS. 3AB protein was incorporated into the vesicles at each concentration and
the release of the dye into the supernatant was measured after the times indicated for each concentration by high performance size exclusion
chromatography using a TSK-3000SW column equilibrated with PBS (pH 7.4, 1 ml/min excitation 496 nm, emission 518 nm).
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ber of instances of transient currents induced by nystatin^er-
gosterol (‘fusion spikes’) that appeared across the bilayer.
These currents are transient because the ergosterol, which is
necessary for nystatin channel formation, di¡uses into the
lipids in an ergosterol-free bilayer once the vesicle incorpo-
rates.
Amino acid analysis was used in conjunction with analysis
of fusion spikes to compute the number of 3AB protein mol-
ecules per channel electrical activity observed. This was done
by measuring the amount of 3AB protein incorporated into
vesicles from a known concentration of the protein. We found
that the average number of 3AB protein molecules per vesicle
depended on the pH at which the vesicles were formed. At pH
7.2, we calculated that the average number of 3AB molecules
per channel activity was 323R 14. We observed that an aver-
age of four fusion events occurred before ion channel activity
was observed. The fraction of molecules that actually partici-
pated in the ion channel-like activity we observed is not
known, but the average number of molecules per activity is
too large to make a convincing case that the electrical activity
was the result of an ion channel [53^55].
A comparison of the evidence that the 3AB protein and the
A/M2 protein have intrinsic ion channel activity is informa-
tive. The biological evidence indicating a need for an ion
channel to provide acidi¢cation of the in£uenza virion is
strong, but the biological evidence indicating that an ion
channel activity was needed during the rhinovirus life cycle
is not as compelling. The evidence for the A/M2 protein in-
cluded the need for acidi¢cation activity for viral uncoating
and association of the A/M2 protein with acidi¢cation activ-
ity. On the other hand, the suspicion that the 3AB protein
might be an ion channel was based only on the hunch that an
ion channel or pore was needed in the replication complex
during the assembly phase of the life cycle. The biophysical
evidence that the A/M2 protein has intrinsic ion channel ac-
tivity is supported by numerous ¢ndings: experiments in
which the activity was recorded in various types of cells, the
correlation of the sensitivity of the ion channel activity of
mutant proteins to amantadine with the amantadine sensitiv-
ity of the virus expressing these mutant proteins, and the
¢nding of ion channel activity from puri¢ed A/M2 protein.
In contrast, the biophysical evidence that the 3AB protein
forms an ion channel during replication is weak. First, its
possible ion channel activity cannot be studied in one of the
most useful expression systems, the Xenopus oocyte, because
upregulation of an endogenous oocyte channel activity fol-
lows injection of mRNA encoding the 3AB protein. Second,
electrical channel activity measured in bilayers requires the
insertion of several hundred 3AB molecules (although this
¢gure is an upper limit), and this activity is not signi¢cantly
inhibited by enviroxime. Third, the increased permeability of
the plasma membrane of cells that express the 3AB protein
might re£ect the same phenomenon that a¡ects cells which
have expressed the A/M2 protein for some time: the condition
of the cell might be a¡ected by the viral protein expression in
such a fashion as to make the permeability increase. Release
of the rhinovirus virion from the infected cell is essential to
replication, but this step could be accomplished either by cell
lysis or with a lipidic pore that would not need the ionic
speci¢city of the A/M2 channel.
4. Conclusion
Comparing the evidence that these two proteins possess
intrinsic ion channel activity shows that the demonstration
of intrinsic activity requires the convergence of many lines
of evidence coming from the biology of the virus and biophys-
ical measurements. No one piece of evidence alone is su⁄cient
to make a convincing case.
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Fig. 4. Activity of crude replication complex from HRV-14 introduced into a planar lipid bilayer using the nystatin^ergosterol technique. Three
replication complex (RC) channel-like activities are demonstrated at 0 mV and +20 mV. Notice the di¡erence in open times between 3AB
(Fig. 2) and RC. NaCl concentrations used for replication complex analysis were identical to those for 3AB analysis but were done in diethyl-
pyrocarbonate-treated water.
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